11 results on '"Karjadi, Cody"'
Search Results
2. Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models.
- Author
-
Amini, Samad, Hao, Boran, Yang, Jingmei, Karjadi, Cody, Kolachalama, Vijaya B., Au, Rhoda, and Paschalidis, Ioannis C.
- Abstract
INTRODUCTION: Identification of individuals with mild cognitive impairment (MCI) who are at risk of developing Alzheimer's disease (AD) is crucial for early intervention and selection of clinical trials. METHODS: We applied natural language processing techniques along with machine learning methods to develop a method for automated prediction of progression to AD within 6 years using speech. The study design was evaluated on the neuropsychological test interviews of n = 166 participants from the Framingham Heart Study, comprising 90 progressive MCI and 76 stable MCI cases. RESULTS: Our best models, which used features generated from speech data, as well as age, sex, and education level, achieved an accuracy of 78.5% and a sensitivity of 81.1% to predict MCI‐to‐AD progression within 6 years. DISCUSSION: The proposed method offers a fully automated procedure, providing an opportunity to develop an inexpensive, broadly accessible, and easy‐to‐administer screening tool for MCI‐to‐AD progression prediction, facilitating development of remote assessment. Highlights: Voice recordings from neuropsychological exams coupled with basic demographics can lead to strong predictive models of progression to dementia from mild cognitive impairment.The study leveraged AI methods for speech recognition and processed the resulting text using language models.The developed AI‐powered pipeline can lead to fully automated assessment that could enable remote and cost‐effective screening and prognosis for Alzehimer's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Speech patterns during memory recall relates to early tau burden across adulthood
- Author
-
Young, Christina B., primary, Smith, Viktorija, additional, Karjadi, Cody, additional, Grogan, Selah‐Marie, additional, Ang, Ting Fang Alvin, additional, Insel, Philip S., additional, Henderson, Victor W., additional, Sumner, Meghan, additional, Poston, Kathleen L., additional, Au, Rhoda, additional, and Mormino, Elizabeth C., additional
- Published
- 2024
- Full Text
- View/download PDF
4. Comparing Cognitive Tests and Smartphone‐Based Assessment in 2 US Community‐Based Cohorts
- Author
-
De Anda‐Duran, Ileana, primary, Sunderaraman, Preeti, additional, Searls, Edward, additional, Moukaled, Shirine, additional, Jin, Xuanyi, additional, Popp, Zachary, additional, Karjadi, Cody, additional, Hwang, Phillip H., additional, Ding, Huitong, additional, Devine, Sherral, additional, Shih, Ludy C., additional, Low, Spencer, additional, Lin, Honghuang, additional, Kolachalama, Vijaya B., additional, Bazzano, Lydia, additional, Libon, David J., additional, and Au, Rhoda, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Design and Feasibility Analysis of a Smartphone‐Based Digital Cognitive Assessment Study in the Framingham Heart Study
- Author
-
Sunderaraman, Preeti, primary, De Anda‐Duran, Ileana, additional, Karjadi, Cody, additional, Peterson, Julia, additional, Ding, Huitong, additional, Devine, Sherral A., additional, Shih, Ludy C., additional, Popp, Zachary, additional, Low, Spencer, additional, Hwang, Phillip H., additional, Goyal, Kriti, additional, Hathaway, Lindsay, additional, Monteverde, Jose, additional, Lin, Honghuang, additional, Kolachalama, Vijaya B., additional, and Au, Rhoda, additional
- Published
- 2024
- Full Text
- View/download PDF
6. Exploring cognitive progression subtypes in the Framingham Heart Study.
- Author
-
Ding, Huitong, Wang, Biqi, Hamel, Alexander P., Karjadi, Cody, Ang, Ting F. A., Au, Rhoda, and Lin, Honghuang
- Subjects
ALZHEIMER'S disease ,COGNITION ,VISUAL memory ,VERBAL learning ,AGE of onset - Abstract
INTRODUCTION: Alzheimer's disease (AD) is a heterogeneous disorder characterized by complex underlying neuropathology that is not fully understood. This study aimed to identify cognitive progression subtypes and examine their correlation with clinical outcomes. METHODS: Participants of this study were recruited from the Framingham Heart Study. The Subtype and Stage Inference (SuStaIn) method was used to identify cognitive progression subtypes based on eight cognitive domains. RESULTS: Three cognitive progression subtypes were identified, including verbal learning (Subtype 1), abstract reasoning (Subtype 2), and visual memory (Subtype 3). These subtypes represent different domains of cognitive decline during the progression of AD. Significant differences in age of onset among the different subtypes were also observed. A higher SuStaIn stage was significantly associated with increased mortality risk. DISCUSSION: This study provides a characterization of AD heterogeneity in cognitive progression, emphasizing the importance of developing personalized approaches for risk stratification and intervention. Highlights: We used the Subtype and Stage Inference (SuStaIn) method to identify three cognitive progression subtypes.Different subtypes have significant variations in age of onset.Higher stages of progression are associated with increased mortality risk. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Detection of Mild Cognitive Impairment From Non-Semantic, Acoustic Voice Features: The Framingham Heart Study.
- Author
-
Ding H, Lister A, Karjadi C, Au R, Lin H, Bischoff B, and Hwang PH
- Subjects
- Humans, Female, Male, Aged, Voice physiology, Machine Learning, Neuropsychological Tests, Middle Aged, Aged, 80 and over, Case-Control Studies, Speech Acoustics, Cognitive Dysfunction diagnosis, Cognitive Dysfunction physiopathology
- Abstract
Background: With the aging global population and the rising burden of Alzheimer disease and related dementias (ADRDs), there is a growing focus on identifying mild cognitive impairment (MCI) to enable timely interventions that could potentially slow down the onset of clinical dementia. The production of speech by an individual is a cognitively complex task that engages various cognitive domains. The ease of audio data collection highlights the potential cost-effectiveness and noninvasive nature of using human speech as a tool for cognitive assessment., Objective: This study aimed to construct a machine learning pipeline that incorporates speaker diarization, feature extraction, feature selection, and classification to identify a set of acoustic features derived from voice recordings that exhibit strong MCI detection capability., Methods: The study included 100 MCI cases and 100 cognitively normal controls matched for age, sex, and education from the Framingham Heart Study. Participants' spoken responses on neuropsychological tests were recorded, and the recorded audio was processed to identify segments of each participant's voice from recordings that included voices of both testers and participants. A comprehensive set of 6385 acoustic features was then extracted from these voice segments using OpenSMILE and Praat software. Subsequently, a random forest model was constructed to classify cognitive status using the features that exhibited significant differences between the MCI and cognitively normal groups. The MCI detection performance of various audio lengths was further examined., Results: An optimal subset of 29 features was identified that resulted in an area under the receiver operating characteristic curve of 0.87, with a 95% CI of 0.81-0.94. The most important acoustic feature for MCI classification was the number of filled pauses (importance score=0.09, P=3.10E-08). There was no substantial difference in the performance of the model trained on the acoustic features derived from different lengths of voice recordings., Conclusions: This study showcases the potential of monitoring changes to nonsemantic and acoustic features of speech as a way of early ADRD detection and motivates future opportunities for using human speech as a measure of brain health., (©Huitong Ding, Adrian Lister, Cody Karjadi, Rhoda Au, Honghuang Lin, Brian Bischoff, Phillip H Hwang. Originally published in JMIR Aging (https://aging.jmir.org), 22.08.2024.)
- Published
- 2024
- Full Text
- View/download PDF
8. Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models.
- Author
-
Amini S, Hao B, Yang J, Karjadi C, Kolachalama VB, Au R, and Paschalidis IC
- Subjects
- Humans, Female, Male, Aged, Natural Language Processing, Aged, 80 and over, Alzheimer Disease diagnosis, Disease Progression, Cognitive Dysfunction diagnosis, Speech, Machine Learning, Neuropsychological Tests statistics & numerical data
- Abstract
Introduction: Identification of individuals with mild cognitive impairment (MCI) who are at risk of developing Alzheimer's disease (AD) is crucial for early intervention and selection of clinical trials., Methods: We applied natural language processing techniques along with machine learning methods to develop a method for automated prediction of progression to AD within 6 years using speech. The study design was evaluated on the neuropsychological test interviews of n = 166 participants from the Framingham Heart Study, comprising 90 progressive MCI and 76 stable MCI cases., Results: Our best models, which used features generated from speech data, as well as age, sex, and education level, achieved an accuracy of 78.5% and a sensitivity of 81.1% to predict MCI-to-AD progression within 6 years., Discussion: The proposed method offers a fully automated procedure, providing an opportunity to develop an inexpensive, broadly accessible, and easy-to-administer screening tool for MCI-to-AD progression prediction, facilitating development of remote assessment., Highlights: Voice recordings from neuropsychological exams coupled with basic demographics can lead to strong predictive models of progression to dementia from mild cognitive impairment. The study leveraged AI methods for speech recognition and processed the resulting text using language models. The developed AI-powered pipeline can lead to fully automated assessment that could enable remote and cost-effective screening and prognosis for Alzehimer's disease., (© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)
- Published
- 2024
- Full Text
- View/download PDF
9. Cerebral Microbleeds in Different Brain Regions and Their Associations With the Digital Clock-Drawing Test: Secondary Analysis of the Framingham Heart Study.
- Author
-
Akhter-Khan SC, Tao Q, Ang TFA, Karjadi C, Itchapurapu IS, Libon DJ, Alosco M, Mez J, Qiu WQ, and Au R
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Magnetic Resonance Imaging methods, Cohort Studies, Alzheimer Disease diagnostic imaging, Alzheimer Disease physiopathology, Cerebral Hemorrhage diagnostic imaging, Brain diagnostic imaging
- Abstract
Background: Cerebral microbleeds (CMB) increase the risk for Alzheimer disease. Current neuroimaging methods that are used to detect CMB are costly and not always accessible., Objective: This study aimed to explore whether the digital clock-drawing test (DCT) may provide a behavioral indicator of CMB., Methods: In this study, we analyzed data from participants in the Framingham Heart Study offspring cohort who underwent both brain magnetic resonance imaging scans (Siemens 1.5T, Siemens Healthcare Private Limited; T2*-GRE weighted sequences) for CMB diagnosis and the DCT as a predictor. Additionally, paper-based clock-drawing tests were also collected during the DCT. Individuals with a history of dementia or stroke were excluded. Robust multivariable linear regression models were used to examine the association between DCT facet scores with CMB prevalence, adjusting for relevant covariates. Receiver operating characteristic (ROC) curve analyses were used to evaluate DCT facet scores as predictors of CMB prevalence. Sensitivity analyses were conducted by further including participants with stroke and dementia., Results: The study sample consisted of 1020 (n=585, 57.35% female) individuals aged 45 years and older (mean 72, SD 7.9 years). Among them, 64 (6.27%) participants exhibited CMB, comprising 46 with lobar-only, 11 with deep-only, and 7 with mixed (lobar+deep) CMB. Individuals with CMB tended to be older and had a higher prevalence of mild cognitive impairment and higher white matter hyperintensities compared to those without CMB (P<.05). While CMB were not associated with the paper-based clock-drawing test, participants with CMB had a lower overall DCT score (CMB: mean 68, SD 23 vs non-CMB: mean 76, SD 20; P=.009) in the univariate comparison. In the robust multiple regression model adjusted for covariates, deep CMB were significantly associated with lower scores on the drawing efficiency (β=-0.65, 95% CI -1.15 to -0.15; P=.01) and simple motor (β=-0.86, 95% CI -1.43 to -0.30; P=.003) domains of the command DCT. In the ROC curve analysis, DCT facets discriminated between no CMB and the CMB subtypes. The area under the ROC curve was 0.76 (95% CI 0.69-0.83) for lobar CMB, 0.88 (95% CI 0.78-0.98) for deep CMB, and 0.98 (95% CI 0.96-1.00) for mixed CMB, where the area under the ROC curve value nearing 1 indicated an accurate model., Conclusions: The study indicates a significant association between CMB, especially deep and mixed types, and reduced performance in drawing efficiency and motor skills as assessed by the DCT. This highlights the potential of the DCT for early detection of CMB and their subtypes, providing a reliable alternative for cognitive assessment and making it a valuable tool for primary care screening before neuroimaging referral., (©Samia C Akhter-Khan, Qiushan Tao, Ting Fang Alvin Ang, Cody Karjadi, Indira Swetha Itchapurapu, David J Libon, Michael Alosco, Jesse Mez, Wei Qiao Qiu, Rhoda Au. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 29.07.2024.)
- Published
- 2024
- Full Text
- View/download PDF
10. AI-based differential diagnosis of dementia etiologies on multimodal data.
- Author
-
Xue C, Kowshik SS, Lteif D, Puducheri S, Jasodanand VH, Zhou OT, Walia AS, Guney OB, Zhang JD, Pham ST, Kaliaev A, Andreu-Arasa VC, Dwyer BC, Farris CW, Hao H, Kedar S, Mian AZ, Murman DL, O'Shea SA, Paul AB, Rohatgi S, Saint-Hilaire MH, Sartor EA, Setty BN, Small JE, Swaminathan A, Taraschenko O, Yuan J, Zhou Y, Zhu S, Karjadi C, Ang TFA, Bargal SA, Plummer BA, Poston KL, Ahangaran M, Au R, and Kolachalama VB
- Abstract
Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an AI model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations, and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51,269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a micro-averaged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the micro-averaged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two co-occurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in various clinical settings and drug trials, with promising implications for person-level management., Competing Interests: Ethics declarations V.B.K. is on the scientific advisory board for Altoida Inc., and serves as a consultant to AstraZeneca. S.K. serves as consultant to AstraZeneca. C.W.F. is a consultant to Boston Imaging Core Lab. K.L.P. is a member of the scientific advisory boards for Curasen, Biohaven, and Neuron23, receiving consulting fees and stock options, and for Amprion, receiving stock options. R.A. is a scientific advisor to Signant Health and NovoNordisk. She also serves as a consultant to Davos Alzheimer’s Collaborative. The remaining authors declare no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
11. Exploring cognitive progression subtypes in the Framingham Heart Study.
- Author
-
Ding H, Wang B, Hamel AP, Karjadi C, Ang TFA, Au R, and Lin H
- Abstract
Introduction: Alzheimer's disease (AD) is a heterogeneous disorder characterized by complex underlying neuropathology that is not fully understood. This study aimed to identify cognitive progression subtypes and examine their correlation with clinical outcomes., Methods: Participants of this study were recruited from the Framingham Heart Study. The Subtype and Stage Inference (SuStaIn) method was used to identify cognitive progression subtypes based on eight cognitive domains., Results: Three cognitive progression subtypes were identified, including verbal learning (Subtype 1), abstract reasoning (Subtype 2), and visual memory (Subtype 3). These subtypes represent different domains of cognitive decline during the progression of AD. Significant differences in age of onset among the different subtypes were also observed. A higher SuStaIn stage was significantly associated with increased mortality risk., Discussion: This study provides a characterization of AD heterogeneity in cognitive progression, emphasizing the importance of developing personalized approaches for risk stratification and intervention., Highlights: We used the Subtype and Stage Inference (SuStaIn) method to identify three cognitive progression subtypes.Different subtypes have significant variations in age of onset.Higher stages of progression are associated with increased mortality risk., Competing Interests: R.A. is a scientific advisor to Signant Health and NovoNordisk, and a consultant to the Davos Alzheimer's Collaborative. The other authors declare no conflicts of interest. Author disclosures are available in the supporting information., (© 2024 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.